Literature DB >> 12433316

Clinical effectiveness and cost-effectiveness of growth hormone in children: a systematic review and economic evaluation.

J Bryant1, C Cave, B Mihaylova, D Chase, L McIntyre, K Gerard, R Milne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12433316     DOI： 10.3310/hta6180

Source DB:  PubMed          Journal:  Health Technol Assess        ISSN： 1366-5278            Impact factor:   4.014


× No keyword cloud information.
  13 in total

1.  In children with idiopathic short stature, what advantage does administering recombinant growth hormone have over observation in final adult height?: Part A: Evidence-based answer and summary.

Authors:  Titus Chan; Terry P Klassen
Journal:  Paediatr Child Health       Date:  2003-11       Impact factor: 2.253

2.  Efficacy and safety of long-acting growth hormone in children with short stature: a systematic review and meta-analysis.

Authors:  Yingying Yang; Xi Bai; Xianxian Yuan; Yuelun Zhang; Shi Chen; Hongbo Yang; Hanze Du; Huijuan Zhu; Hui Pan
Journal:  Endocrine       Date:  2019-05-22       Impact factor: 3.633

3.  Assessment and treatment of short stature in pediatric patients with chronic kidney disease: a consensus statement.

Authors:  John D Mahan; Bradley A Warady
Journal:  Pediatr Nephrol       Date:  2006-05-30       Impact factor: 3.714

Review 4.  Recombinant growth hormone therapy for X-linked hypophosphatemia in children.

Authors:  Sherie Smith; Tracey Remmington
Journal:  Cochrane Database Syst Rev       Date:  2021-10-07

5.  Partial rescue of growth failure in growth hormone (GH)-deficient mice by a single injection of a double-stranded adeno-associated viral vector expressing the GH gene driven by a muscle-specific regulatory cassette.

Authors:  Marco Martari; Alessia Sagazio; Ali Mohamadi; Quynh Nguyen; Stephen D Hauschka; Eun Kim; Roberto Salvatori
Journal:  Hum Gene Ther       Date:  2009-07       Impact factor: 5.695

Review 6.  Recombinant growth hormone therapy for cystic fibrosis in children and young adults.

Authors:  Vidhu Thaker; Alexandra L Haagensen; Ben Carter; Zbys Fedorowicz; Brian W Houston
Journal:  Cochrane Database Syst Rev       Date:  2013-06-05

7.  Effects and safety of combination therapy with gonadotropin-releasing hormone analogue and growth hormone in girls with idiopathic central precocious puberty: a meta-analysis.

Authors:  S Liu; Q Liu; X Cheng; Y Luo; Y Wen
Journal:  J Endocrinol Invest       Date:  2016-05-25       Impact factor: 4.256

Review 8.  Growth hormone therapy and quality of life in adults and children.

Authors:  Deborah J Radcliffe; Joseph S Pliskin; J B Silvers; Leona Cuttler
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

9.  Implications of a data-driven approach to treatment with growth hormone in children with growth hormone deficiency and Turner syndrome.

Authors:  Stefan Kaspers; Michael B Ranke; Donald Han; Jane Loftus; Hartmut Wollmann; Anders Lindberg; Mathieu Roelants; Joris Kleintjens
Journal:  Appl Health Econ Health Policy       Date:  2013-06       Impact factor: 2.561

10.  Recombinant growth hormone therapy for cystic fibrosis in children and young adults.

Authors:  Vidhu Thaker; Ben Carter; Melissa Putman
Journal:  Cochrane Database Syst Rev       Date:  2018-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.